2014
DOI: 10.5334/jbr-btr.20
|View full text |Cite
|
Sign up to set email alerts
|

Unilateral giant cell lesion of the jaw in Noonan syndrome

Abstract: noonan syndrome (ns) is an etiologically heterogeneous disorder caused by mutations in the ras-maPK signaling pathway. noonan-like/multiple giant Cell lesion (nl/mgCl) syndrome is initially described as the occurrence of multiple gnathic giant cell lesions in patients with phenotypic features of ns. nowadays, ns/mgCl syndrome is considered a variant of the ns spectrum rather than a distinct entity. we report the case of a 14-year-old female patient carrying a SOS1 mutation with a unilateral giant cell lesion o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…Karbach et al (2012) noticed that individuals harboring variants in SOS1 were overrepresented in the group with GCL. Since their report, five other cases have been described in the literature (Carapito et al, 2014; Eyselbergs et al, 2014; Lutz et al, 2020; Rodríguez, Castellón, Moreno, Paez, & Aracena Álvarez, 2020; Sinnott & Patel, 2018) and including the present data, there are 16 individuals with variants in PTPN11 and 15 individuals with variants in SOS1 , giving further support to the idea that individuals harboring variants in SOS1 could present a higher risk for the development of GCL compared with the ones with variants in PTPN11 .…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…Karbach et al (2012) noticed that individuals harboring variants in SOS1 were overrepresented in the group with GCL. Since their report, five other cases have been described in the literature (Carapito et al, 2014; Eyselbergs et al, 2014; Lutz et al, 2020; Rodríguez, Castellón, Moreno, Paez, & Aracena Álvarez, 2020; Sinnott & Patel, 2018) and including the present data, there are 16 individuals with variants in PTPN11 and 15 individuals with variants in SOS1 , giving further support to the idea that individuals harboring variants in SOS1 could present a higher risk for the development of GCL compared with the ones with variants in PTPN11 .…”
Section: Discussionmentioning
confidence: 95%
“…Karbach et al (2012) noticed that individuals harboring variants in SOS1 were overrepresented in the group with GCL. Since their report, five other cases have been described in the literature (Carapito et al, 2014;Eyselbergs et al, 2014;Lutz et al, 2020;Rodríguez, Castellón, Moreno, Paez, & Aracena Alvarez, 2020;Sinnott & Patel, 2018) and (Figure 3). Iliac bone lesions in NS are uncommon.…”
Section: Factors and Conditions Interfering In The Outcome In Rasopmentioning
confidence: 97%
“…Patient 1 had three separate giant cell tumors in the naso‐maxilla. Giant cell tumors of the jaws and other bone/soft tissues have repeatedly been reported in patients with NS and mutations in PTPN11 and SOS1 (Eyselbergs et al, ; Karbach, Coerdt, Wagner, & Bartsch, ; Neumann et al, ; van den Berg et al, ). These tumors are often multilocular.…”
Section: Discussionmentioning
confidence: 99%
“…Multifocal involvement is seen in hyperparathyroidism, cherubism, or Noonan's syndrome. 38 The most common radiographic findings are complete or partial loss of lamina dura of the teeth and ground-glass appearance of the jaw bones. Rarely, lytic lesions in the jaws may present as reparative giant cell granulomas, 39 characterized by bone expansion and cortical thinning.…”
Section: Giant Cell Lesion Of Hyperparathyroidismmentioning
confidence: 99%